Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Purchased by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 25.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 27,668 shares of the medical instruments supplier’s stock after buying an additional 5,560 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Mesa Laboratories were worth $3,649,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Creative Planning grew its position in Mesa Laboratories by 100.3% during the 3rd quarter. Creative Planning now owns 5,389 shares of the medical instruments supplier’s stock worth $700,000 after purchasing an additional 2,698 shares in the last quarter. Amalgamated Bank grew its position in Mesa Laboratories by 6.5% during the 3rd quarter. Amalgamated Bank now owns 1,588 shares of the medical instruments supplier’s stock worth $206,000 after purchasing an additional 97 shares in the last quarter. Principal Financial Group Inc. grew its position in Mesa Laboratories by 21.8% during the 3rd quarter. Principal Financial Group Inc. now owns 35,107 shares of the medical instruments supplier’s stock worth $4,559,000 after purchasing an additional 6,292 shares in the last quarter. Victory Capital Management Inc. grew its position in Mesa Laboratories by 90.3% during the 3rd quarter. Victory Capital Management Inc. now owns 14,001 shares of the medical instruments supplier’s stock worth $1,818,000 after purchasing an additional 6,643 shares in the last quarter. Finally, Geneva Capital Management LLC grew its position in Mesa Laboratories by 2.0% during the 3rd quarter. Geneva Capital Management LLC now owns 191,976 shares of the medical instruments supplier’s stock worth $24,930,000 after purchasing an additional 3,732 shares in the last quarter. Institutional investors and hedge funds own 90.60% of the company’s stock.

Mesa Laboratories Trading Down 0.5 %

NASDAQ MLAB opened at $144.96 on Wednesday. The firm’s 50 day moving average price is $137.48 and its two-hundred day moving average price is $127.81. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.51 and a current ratio of 0.71. Mesa Laboratories, Inc. has a twelve month low of $83.68 and a twelve month high of $155.12. The stock has a market cap of $787.13 million, a price-to-earnings ratio of -3.13 and a beta of 0.83.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, beating the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. Equities analysts anticipate that Mesa Laboratories, Inc. will post 7.39 EPS for the current year.

Mesa Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, February 28th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.44%. The ex-dividend date is Friday, February 28th. Mesa Laboratories’s dividend payout ratio is currently -1.38%.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, November 13th.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.